Join us at Discovery Europe and network with us and over 400 industry leaders. We will be there to discuss the latest advancements in ultra-High Throughput Screening, Mass Spectrometry, ASMS, target identification, validation and HIT optimization.
The 2-day program addresses emerging strategies for drug development within Neuroscience and successful approaches for more targeted, precise, and transformative therapies to neurodegenerative and neuropsychiatric diseases.
Click here for more information about the conference.
Tuesday June 6th
Track 3: 09:20-09:50 AM
Dr. Saman Honarnejad
“Evaluating target engagement of a focused lead-like and pan-assay interference compound collection using affinity selection mass spectrometry”.
Will you meet us there? Schedule your appointment with our experts here directly!
